CURRICULUM VITAE

with Osteoarthritis Protocol 061-00/COX523. Merck & Co., Inc., 2003. Multinational, Multicenter, Double-Blind, Randomized, Placebo Controlled, Parallel Group Study Assessing the Efficacy of Intravenous Zoledronic Acid in Preventing Subsequent Osteoporotic Fractures after a Hip Fracture. ................
................